References
- Nieswandt B, Watson SP. Platelet-collagen interaction: is GPVI the central receptor? Blood 2003;102(2):449–461. doi:https://doi.org/10.1182/blood-2002-12-3882.
- Zahid M, Mangin P, Loyau S, Hechler B, Billiald P, Gachet C, Jandrot-Perrus M The future of glycoprotein VI as an antithrombotic target. J Thromb Haemost 2012;10(12):2418–2427. doi:https://doi.org/10.1111/jth.12009.
- Alshehri OM, Hughes CE, Montague S, Watson SK, Frampton J, Bender M, Watson SP Fibrin activates GPVI in human and mouse platelets. Blood 2015;126(13):1601–1608. doi:https://doi.org/10.1182/blood-2015-04-641654.
- Mammadova-Bach E, Ollivier V, Loyau S, Schaff M, Dumont B, Favier R, Freyburger G, Latger-Cannard V, Nieswandt B, Gachet C, et al. Platelet glycoprotein VI binds to polymerized fibrin and promotes thrombin generation. Blood 2015;126(5):683–691. doi:https://doi.org/10.1182/blood-2015-02-629717.
- Nieswandt B, Bergmeier W, Schulte V, Rackebrandt K, Gessner JE, Zirngibl H Expression and function of the mouse collagen receptor glycoprotein VI is strictly dependent on its association with the FcRgamma chain. J Biol Chem 2000;275(31):23998–24002. doi:https://doi.org/10.1074/jbc.M003803200.
- Jandrot-Perrus M, Hermans C, Mezzano D. Platelet glycoprotein VI genetic quantitative and qualitative defects. Platelets 2019;30(6):708–713. doi:https://doi.org/10.1080/09537104.2019.1610166.
- Nurden AT. Clinical significance of altered collagen-receptor functioning in platelets with emphasis on glycoprotein VI. Blood Rev 2019;38:100592. doi:https://doi.org/10.1016/j.blre.2019.100592.
- Rabie T, Varga-Szabo D, Bender M, Pozgaj R, Lanza F, Saito T, Watson SP, Nieswandt B Diverging signaling events control the pathway of GPVI down-regulation in vivo. Blood 2007;110(2):529–535. doi:https://doi.org/10.1182/blood-2006-11-058107.
- Gardiner EE, Al-Tamimi M, Mu FT, Karunakaran D, Thom JY, Moroi M, Andrews RK, Berndt MC, Baker RI. Compromised ITAM-based platelet receptor function in a patient with immune thrombocytopenic purpura. J Thromb Haemost 2008;6(7):1175–1182. doi:https://doi.org/10.1111/j.1538-7836.2008.03016.x.
- Kunishima S, Okuno Y, Yoshida K, Shiraishi Y, Sanada M, Muramatsu H, Chiba K, Tanaka H, Miyazaki K, Sakai M ACTN1 mutations cause congenital macrothrombocytopenia. Am J Hum Genet 2013;92(3):431–438. doi:https://doi.org/10.1016/j.ajhg.2013.01.015.
- Westbury SK, Turro E, Greene D, Lentaigne C, Kelly AM, Bariana TK, Simeoni I, Pillois X, Attwood A, Austin S Human phenotype ontology annotation and cluster analysis to unravel genetic defects in 707 cases with unexplained bleeding and platelet disorders. Genome Med 2015;7(1):36. doi:https://doi.org/10.1186/s13073-015-0151-5.
- McFadyen JD, Schaff M, Peter K. Current and future antiplatelet therapies: emphasis on preserving haemostasis. Nat Rev Cardiol 2018;15(3):181–191. doi:https://doi.org/10.1038/nrcardio.2017.206.